Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Hambleton

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancerHerbert I Hurwitz, Louis Fehrenbacher, John D Hainsworth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancerStephen A Cannistra, Ursula A Matulonis, Richard T Penson, et al.
Anesthesia and Analgesia|May 25, 2004
Reversal of direct thrombin inhibition after cardiopulmonary bypass in a patient with heparin-induced thrombocytopeniaGreg Stratmann, Anil M deSilva, Elaine E Tseng, et al.
Blood|November 15, 2003
Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factorsJ Michael Soucie, Christy Cianfrini, Robert L Janco, et al.
Transfusion|August 5, 2005
Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficienciesPedro de Alarcon, Richard Benjamin, Marion Dugdale, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2009
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumorsCrystal S Denlinger, Rebecca Blanchard, Lu Xu, et al.
Blood|September 16, 2008
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trialClive Kearon, Jim A Julian, Michael J Kovacs, et al.
The New England Journal of Medicine|August 15, 2003
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolismClive Kearon, Jeffrey S Ginsberg, Michael J Kovacs, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancerHerbert I Hurwitz, Louis Fehrenbacher, John D Hainsworth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancerStephen A Cannistra, Ursula A Matulonis, Richard T Penson, et al.
Anesthesia and Analgesia|May 25, 2004
Reversal of direct thrombin inhibition after cardiopulmonary bypass in a patient with heparin-induced thrombocytopeniaGreg Stratmann, Anil M deSilva, Elaine E Tseng, et al.
Blood|November 15, 2003
Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factorsJ Michael Soucie, Christy Cianfrini, Robert L Janco, et al.
Transfusion|August 5, 2005
Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficienciesPedro de Alarcon, Richard Benjamin, Marion Dugdale, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2009
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumorsCrystal S Denlinger, Rebecca Blanchard, Lu Xu, et al.
Blood|September 16, 2008
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trialClive Kearon, Jim A Julian, Michael J Kovacs, et al.
The New England Journal of Medicine|August 15, 2003
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolismClive Kearon, Jeffrey S Ginsberg, Michael J Kovacs, et al.
Pageof 2